– UK, London – Brooks Macdonald Group plc (LON: BRK) today announced the appointment of James Rawlingson to its Board as Non-Executive Director, effective 2 March 2023.
“I am delighted that James is joining the Board. James has had an extensive career and his sector experience will provide valuable insight as the Company continues towards its strategic goals.” said acting Chairman Richard Price.
James will also join the Audit Committee as its Chairman, subject to regulatory approval.
About James Rawlingson
James Rawlingson currently serves as Chairman of the Audit and Risk Committee at Citibank UK, Chairman of the Audit and Risk Assurance Committee at the Foreign Office’s executive agency Wilton Park, and Chairman of the Board at Novai Ltd. In his executive career, James has held senior positions at Coutts, UBS Wealth, Charles Stanley plc, and Arix Bioscience plc.
About Brooks Macdonald Group plc
Brooks Macdonald Group plc, through its various subsidiaries, provides leading investment management services in the UK and internationally. The Group, which was founded in 1991 and began trading on AIM in 2005, had discretionary Funds under Management of £16.2 billion as of 31 December 2022.
Brooks Macdonald offers a range of investment management services to private high-net-worth individuals, pension funds, institutions, charities, and trusts. The Group also provides financial planning as well as international investment management and acts as a fund manager to a range of onshore and international funds.
The Group has fifteen offices across the UK and Crown Dependencies including London, Birmingham, Cheltenham, East Anglia, Exeter, Leeds, Manchester, Nuneaton, Southampton, Tunbridge Wells, Scotland, Wales, Jersey, Guernsey, and Isle of Man.
For more information: https://www.brooksmacdonald.com
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
